Gibson Dunn has advised Cytokinetics, Incorporated. Latham & Watkins LLP has advised the underwriters. Cytokinetics, Incorporated (Nasdaq: CYTK) completed a public offering of 11,338,028 shares of…
Cytokinetics Raises $805 Million in Public Offering of Common Stock
